Cat. No.
MABL-3489
Application
functional assay, in vivo, ELISA
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
RHD5
From
Recombinant Antibody
Specificity
This antibody is specific for the C1 domain of Factor VIII.
Alternative Names
AHF; Coagulation factor VIII; Antihemophilic factor; Procoagulant component
UniProt
P00451
Immunogen
This antibody was raised from B lymphocytes from a patient who developed an autoimmune response to Factor VIII.
Application Notes
Exhibited binding to Factor VIII in ELISA. Bethesda assay shows partial FVIII inhibition, achieving 97% inhibition at 100 μg/mL. In human plasma it inhibits 80% of Factor VIII; displays no inhibitory activity against mouse endogenous Factor VIII, but partially inhibits recombinant human Factor VIII added to FVIII‑deficient mouse plasma. In‑vivo test in Factor VIII‑deficient mice demonstrated only partial inhibition when co‑administered with human Factor VIII (US8784816B2).
Antibody First Published
Coxon et al. Characterisation and application of recombinant FVIII-neutralising antibodies from haemophilia A inhibitor patients Br J Haematol. 2021 Jun;193(5):976-987. PMID:33973229
Note on publication
In the original paper there were two aims to the work: (i) to develop and characterise a panel of recombinant, patient-derived, monoclonal antibodies covering a range of FVIII epitopes with varying potencies, kinetics and mechanism of action, and (ii) to demonstrate their applicability to assay development, evaluation of FVIII molecules and basic research.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


